Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast Cancer

Name: Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast Cancer
Published: 2007
License: Public Domain

GlaxoSmithKline · 2007

ClinicalTrials.gov · Datasets · License: Public Domain · 2007

Open Source ↗

breast breast-cancer neoplasms skin

neoplasms, breast, gw572016, breast cancer, recist, inflammatory breast cancer, pazopanib, erbb2, cutaneous disease, tykerb, inflammatory, skin, her2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 888671
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.